Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

Prevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a case-control study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. EDTAKI: a Nephrology and Public Policy Committee platform call for more European involvement in acute kidney injury

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Early Coronary Atherosclerosis in Women With Previous Preeclampsia

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Aortic enlargement and coronary artery calcification in a general population cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease and represents a wide spectrum ranging from mild steatosis over non-alcoholic steatohepatitis with and without fibrosis to overt cirrhosis. Patients with NAFLD have a high risk of developing cardiovascular disease and chronic kidney disease (CKD). So far, there is scarce evidence of the prevalence of NAFLD among patients with CKD. We investigated the prevalence of moderate-to-severe hepatic steatosis graded according to the definition of NAFLD in a cohort of patients with CKD.

METHODS: Hepatic liver fat content was evaluated by computed tomography (CT) scan in 291 patients from the Copenhagen Chronic Kidney Disease Cohort Study and in 866 age- and sex-matched individuals with normal kidney function from the Copenhagen General Population Study. Liver attenuation density <48 Hounsfield units was used as cut-off value for moderate-to-severe hepatic steatosis.

RESULTS: The prevalence of moderate-to-severe hepatic steatosis was 7.9% and 10.7% (P = 0.177) among patients with CKD and controls, respectively. No association between liver fat content and CKD stage was found. In the pooled data set from both cohorts, adjusted odds ratios for moderate-to-severe hepatic steatosis among persons with diabetes, overweight and obesity amounted to 3.1 (95% confidence interval (CI) 1.6-5.9), 14.8 (95% CI 4.6-47.9) and 42.0 (95% CI 12.9-136.6), respectively.

CONCLUSIONS: In a cohort of 291 patients with CKD, kidney function was not associated with the prevalence of moderate-to-severe hepatic steatosis as assessed by CT scan.

Original languageEnglish
JournalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN0931-0509
DOIs
Publication statusE-pub ahead of print - 2022

Bibliographical note

© The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

    Research areas

  • chronic kidney disease, computed tomography, diabetes, hepatic steatosis, non-alcoholic fatty liver disease

ID: 69730650